patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Mr. Craig Bird answers investor's question re change of symbol..below

Mr. Craig Bird answers investor's question re change of symbol..below

posted on Nov 28, 2007 02:39PM
Re: Craig.....some questions


Hi Chip,

#1) NASDAQ changed the symbol, not Pluristem -

#2) I am not aware of an application for listing on the Tel Aviv
Exchange. I do know that there are several Israeli investors in
Pluristem, but they buy their shares on the U.S. market.

#3) To my knowledge, Pluristem has met all NAZDAQ requirements, except
keeping the bid price at $5 or greater for 5 straight days. I believe
once they complete this last requirement, they will be listed on NASDAQ.

Respectfully,

Craig


Share
New Message
Please login to post a reply